Cookie Consent by Free Privacy Policy website Misty Robotics Announces General Availability of the Temp Screening Assistant
gennaio 11, 2021 - Misty Robotics

Misty Robotics Announces General Availability of the Temp Screening Assistant

Comunicato Stampa disponibile solo in lingua originale. 

Putting Misty II to Work in the Role of Temperature and #health Screening for COVID-19 Increases Safety, Efficiency, and Affordability

Boulder, CO — January, 11, 2021 — #mistyrobotics, the creators of the Misty II platform #robot, today announced the General Availability of the Temp Screening Assistant. After successful completion of its pilot program with multiple healthcare institutions and other organizations, the product is now commercially available. This is the only temperature screening solution to employ a #robot with character, Misty II, delivering efficiency, affordability, high accuracy and safety for employees, patients and visitors.

The Misty II #robot has been equipped with a high accuracy, thermal imaging camera, temperature reference device, and a screening application that leverages her natural personality. There are two versions available to meet the specific screening needs of the organization. The capabilities of the Core version include:

  • Closed-loop temperature screening (accuracy within +/- 0.5 C)
  • An interactive #health question survey
  • Immediate pass/fail result determination and recording
  • Configurable SMS and/or email notifications
  • Web-based administration and reporting
  • First of its kind, dynamic character interaction
  • A great unflappable attitude

Customers can upgrade from the Core version to the Specialized version, gaining the opportunity to customize screening questions and greetings, have an optional temperature readout on Misty’s screen and the leverage the ability to print “I’ve been screened” stickers.

“This is a complete use case built for a platform #robot, proving the value and future potential of robots as platforms,” shared Tim Enwall, CEO of #mistyrobotics. “By putting Misty II to work in this role, we are helping healthcare organizations and businesses increase safety, save money, be more efficient, while dealing with the day-to-day work challenges of the pandemic.”

The solution commonly seen for temperature screening today is a human, either a staff member or individual hired from a third-party firm. Based on feedback from pilot customers, Misty II in this role is:

  • Efficient - Get employees back to their day job and/or extend resources
  • Affordable – Rapid ROI with payback in as little as one month
  • Accurate – Advanced thermal camera with accuracy within +/- 0.5 C
  • Automated - Take operator error out of the picture and keep employees safe
  • Fast – Enable screening in as quickly as 30 seconds per individual
  • Contactless – No surfaces to clean keeping users safe and eliminating costs
  • Trackable – Data to support audits, contact tracing and other needs
  • Personable – Create a fun and friendly user experience

"We calculated the payback period (for putting Misty to work as our temperature screener) at 1 month,” offered Per Schenck, Mental #health Partners #health and Safety Coordinator. “Misty is seen as a tool to save money and utilize staff for other important duties.”

“This is an innovative solution, but not intimidating patients,” shared Gary Bateman, CIO of Adair County #health System.

Pricing for the Temp Screener Assistant starts at $3,299 + a modest monthly fee. A per-month price model is also available.

News correlate

gennaio 18, 2021
gennaio 18, 2021
gennaio 18, 2021

Comunicato Stampa disponibile solo in lingua originale. TAIPEI, Jan. 18, 2021 /PRNewswire/ --  Hospitals and healthcare systems ac...

Comunicato Stampa disponibile solo in lingua originale. TAIPEI, Taiwan, Jan. 17, 2021 /PRNewswire/ -- The World #health Organizati...

Comunicato Stampa disponibile solo in lingua originale. Highlights from #dell, #lenovo, #hp, #acer, #zagg and #lgdisplay, includin...

Ti potrebbe interessare anche

gennaio 15, 2021
gennaio 15, 2021
gennaio 15, 2021

Comunicato Stampa disponibile solo in lingua originale. TAIPEI, Jan. 12, 2021 /PRNewswire/ -- The COVID-19 pandemic has led to the...

Comunicato Stampa disponibile solo in lingua originale. TAIPEI, Jan. 12, 2021 /PRNewswire/ -- The COVID-19 pandemic has led to the...

Comunicato Stampa disponibile solo in lingua originale. TAIPEI, Jan. 15, 2021 /PRNewswire/ -- Chinese medicine has been receiving ...